TW200514784A - Sulfonamide substituted imidazoquinolines - Google Patents
Sulfonamide substituted imidazoquinolinesInfo
- Publication number
- TW200514784A TW200514784A TW093118635A TW93118635A TW200514784A TW 200514784 A TW200514784 A TW 200514784A TW 093118635 A TW093118635 A TW 093118635A TW 93118635 A TW93118635 A TW 93118635A TW 200514784 A TW200514784 A TW 200514784A
- Authority
- TW
- Taiwan
- Prior art keywords
- sulfonamide substituted
- useful
- substituted imidazoquinolines
- compounds
- imidazoquinolines
- Prior art date
Links
- 125000000565 sulfonamide group Chemical group 0.000 title abstract 2
- RHKWIGHJGOEUSM-UHFFFAOYSA-N 3h-imidazo[4,5-h]quinoline Chemical class C1=CN=C2C(N=CN3)=C3C=CC2=C1 RHKWIGHJGOEUSM-UHFFFAOYSA-N 0.000 title 1
- 229940124530 sulfonamide Drugs 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- GCGNWZMOENODOJ-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1h-imidazo[4,5-h]quinoline Chemical class C1C=C2C=CC=NC2=C2C1NCN2 GCGNWZMOENODOJ-UHFFFAOYSA-N 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- SQQXRXKYTKFFSM-UHFFFAOYSA-N chembl1992147 Chemical compound OC1=C(OC)C(OC)=CC=C1C1=C(C)C(C(O)=O)=NC(C=2N=C3C4=NC(C)(C)N=C4C(OC)=C(O)C3=CC=2)=C1N SQQXRXKYTKFFSM-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940124669 imidazoquinoline Drugs 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003607 modifier Substances 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48320003P | 2003-06-27 | 2003-06-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200514784A true TW200514784A (en) | 2005-05-01 |
Family
ID=33563911
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093118635A TW200514784A (en) | 2003-06-27 | 2004-06-25 | Sulfonamide substituted imidazoquinolines |
| TW093118636A TW200511992A (en) | 2003-06-27 | 2004-06-25 | Sulfonamide substituted imidazoquinolines |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093118636A TW200511992A (en) | 2003-06-27 | 2004-06-25 | Sulfonamide substituted imidazoquinolines |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1638566A4 (fr) |
| JP (1) | JP2007521280A (fr) |
| KR (1) | KR20060035637A (fr) |
| CN (1) | CN1812789B (fr) |
| AR (2) | AR044923A1 (fr) |
| AU (1) | AU2004253929A1 (fr) |
| BR (1) | BRPI0411916A (fr) |
| CA (1) | CA2529322A1 (fr) |
| IL (1) | IL172427A0 (fr) |
| MX (1) | MXPA06000144A (fr) |
| MY (1) | MY157827A (fr) |
| NZ (1) | NZ544330A (fr) |
| RU (1) | RU2374246C2 (fr) |
| TW (2) | TW200514784A (fr) |
| WO (2) | WO2005003064A2 (fr) |
| ZA (1) | ZA200600769B (fr) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040265351A1 (en) | 2003-04-10 | 2004-12-30 | Miller Richard L. | Methods and compositions for enhancing immune response |
| WO2005018556A2 (fr) | 2003-08-12 | 2005-03-03 | 3M Innovative Properties Company | Composes contenant une structure imidazo a substitution hydroxylamine |
| PH12006500401A1 (en) | 2003-08-27 | 2005-03-10 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| EP1660026A4 (fr) | 2003-09-05 | 2008-07-16 | 3M Innovative Properties Co | Traitement pour le lymphome a cellules b cd5+ |
| CA2540598C (fr) | 2003-10-03 | 2013-09-24 | 3M Innovative Properties Company | Pyrazolopyridines et analogues de celles-ci |
| EP1673087B1 (fr) | 2003-10-03 | 2015-05-13 | 3M Innovative Properties Company | Imidazoquinolines a substitution alcoxy |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| WO2005048945A2 (fr) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Composes d'un anneau d'imidazo substitue par hydroxylamine |
| EP1685129A4 (fr) | 2003-11-14 | 2008-10-22 | 3M Innovative Properties Co | Composes d'un anneau d'imidazo substitues par oxime |
| CA2547020C (fr) | 2003-11-25 | 2014-03-25 | 3M Innovative Properties Company | Derives de 1h-imidazo[4,5-c]pyridine-4-amine en tant que compose modificateur de la reponse immunitaire |
| WO2005055932A2 (fr) * | 2003-12-02 | 2005-06-23 | 3M Innovative Properties Company | Combinaisons therapeutiques et methodes faisant appel a des composes irm |
| US8802853B2 (en) | 2003-12-29 | 2014-08-12 | 3M Innovative Properties Company | Arylalkenyl and arylalkynyl substituted imidazoquinolines |
| WO2005066169A2 (fr) | 2003-12-30 | 2005-07-21 | 3M Innovative Properties Company | Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle |
| AU2005228150A1 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| WO2006065280A2 (fr) | 2004-06-18 | 2006-06-22 | 3M Innovative Properties Company | Composes a noyau imidazo a substitutif d'isoxazole, de dihydroisoxazole et d'oxadiazole |
| US8541438B2 (en) | 2004-06-18 | 2013-09-24 | 3M Innovative Properties Company | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| US8026366B2 (en) | 2004-06-18 | 2011-09-27 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
| WO2006038923A2 (fr) | 2004-06-18 | 2006-04-13 | 3M Innovative Properties Company | Imidazonaphthyridines substituees par aryle |
| AU2005322898B2 (en) | 2004-12-30 | 2011-11-24 | 3M Innovative Properties Company | Chiral fused (1,2)imidazo(4,5-c) ring compounds |
| JP5313502B2 (ja) | 2004-12-30 | 2013-10-09 | スリーエム イノベイティブ プロパティズ カンパニー | 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物 |
| ZA200706251B (en) * | 2004-12-30 | 2008-11-26 | Coley Pharm Group Inc | Immune response modifier formulations and methods |
| CA2597092A1 (fr) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Formulations des gel aqueux contenant des modificateurs de reponse immunitaire |
| WO2006086449A2 (fr) | 2005-02-09 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Thiazoloquinolines et thiazolonaphthyridines a substitution alcoxy |
| CA2597587A1 (fr) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Composes cycliques imidazo[4,5-c] substitues par oxime et hydroxylamine et procedes associes |
| EP1863814A1 (fr) | 2005-04-01 | 2007-12-12 | Coley Pharmaceutical Group, Inc. | Composes cycliques 1-pyrazolo (3,4-c) substitues comme modulateurs de la biosynthese de cytokine destines au traitement d'infections virales et de maladies neoplastiques |
| EP1869043A2 (fr) | 2005-04-01 | 2007-12-26 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridine-1,4-diamines et analogues associes |
| AU2006287270A1 (en) | 2005-09-09 | 2007-03-15 | Coley Pharmaceutical Group, Inc. | Amide and carbamate derivatives of N-{2-[4-amino-2- (ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide and methods |
| ZA200803029B (en) * | 2005-09-09 | 2009-02-25 | Coley Pharm Group Inc | Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods |
| WO2007035935A1 (fr) * | 2005-09-23 | 2007-03-29 | Coley Pharmaceutical Group, Inc. | Procede de preparation de 1h-imidazo[4,5-c]pyridines et d'analogues de ceux-ci |
| US8951528B2 (en) | 2006-02-22 | 2015-02-10 | 3M Innovative Properties Company | Immune response modifier conjugates |
| WO2008008432A2 (fr) | 2006-07-12 | 2008-01-17 | Coley Pharmaceutical Group, Inc. | Composés à cycle [1,2] imidazo [4,5-c] fusionné chiral substitué et procédés correspondants |
| HRP20131139T1 (hr) * | 2008-03-24 | 2014-01-03 | 4Sc Discovery Gmbh | Novi supstituirani imidazokinolini |
| EP3222621B1 (fr) | 2010-08-17 | 2023-03-08 | 3M Innovative Properties Company | Composé de modificateur de réponse immunitaire lipidée et son utilisation médicale |
| WO2012167088A1 (fr) | 2011-06-03 | 2012-12-06 | 3M Innovative Properties Company | Lieurs hétérobifonctionnels comportant de segments de polyéthylène glycol et conjugués modificateurs de réponse immunitaire obtenus à partir de ceux-ci |
| EP3366311B1 (fr) | 2011-06-03 | 2020-02-26 | 3M Innovative Properties Co. | Hydrazino-1h-imidazoquinoléine-4-amines et conjugués obtenus à partir de celles-ci |
| US9695171B2 (en) | 2013-12-17 | 2017-07-04 | Pfizer Inc. | 3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors |
| JP6873980B2 (ja) | 2015-09-14 | 2021-05-19 | ファイザー・インク | ＬＲＲＫ２阻害薬としての新規のイミダゾ［４，５−ｃ］キノリンおよびイミダゾ［４，５−ｃ］［１，５］ナフチリジン誘導体 |
| EP3484518B1 (fr) | 2016-07-07 | 2024-08-14 | The Board of Trustees of the Leland Stanford Junior University | Conjugués d'adjuvant d'anticorps |
| SG11201908322WA (en) | 2017-03-10 | 2019-10-30 | Pfizer | Novel imidazo[4,5-c]quinoline derivatives as lrrk2 inhibitors |
| PL3679025T3 (pl) | 2017-09-06 | 2022-07-11 | BioNTech SE | Podstawione imidazochinoliny jako agoniści tlr7 |
| CA3086439A1 (fr) | 2017-12-20 | 2019-06-27 | 3M Innovative Properties Company | Composes imidazo [4,5-c]quinoleine a substitution amide ayant un groupe de liaison a chaine ramifiee destines a etre utilises en tant que modificateur de la reponse immunitaire |
| JP2022525594A (ja) | 2019-03-15 | 2022-05-18 | ボルト バイオセラピューティクス、インコーポレーテッド | Ｈｅｒ２を標的とする免疫結合体 |
| CA3161668A1 (fr) * | 2019-12-20 | 2021-06-24 | Nammi Therapeutics, Inc. | Compositions liposomales formulees et/ou co-formulees contenant des promedicaments agonistes de recepteurs de type toll (« tlr ») utiles dans le traitement du cancer et methodes a ssociees |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH31245A (en) * | 1991-10-30 | 1998-06-18 | Janssen Pharmaceutica Nv | 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives. |
| EP0894797A4 (fr) * | 1997-01-09 | 2001-08-16 | Terumo Corp | Nouveaux derives d'amide et intermediaires utilises pour leur synthese |
| IL124914A (en) * | 1997-06-26 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical compositions containing 6-aryl-2,3,5,6-tetrahydroimidazo¬2,1-a¾isoquinoline derivatives and some new such compounds |
| JP2000119271A (ja) * | 1998-08-12 | 2000-04-25 | Hokuriku Seiyaku Co Ltd | １ｈ―イミダゾピリジン誘導体 |
| EP2145883A1 (fr) * | 1998-10-26 | 2010-01-20 | The Research Foundation Of The State University Of New York | Dérivés dibezyl acide lipoïque et utilisation pour le traitement des maladies |
| US6331539B1 (en) * | 1999-06-10 | 2001-12-18 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
| EP1719511B1 (fr) * | 2001-11-16 | 2008-12-10 | 3M Innovative Properties Company | N-[4-(4-amino-2-éthyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide, composition pharmaceutique le contenant et son utilisation |
| US6677349B1 (en) * | 2001-12-21 | 2004-01-13 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
-
2004
- 2004-06-24 MY MYPI20042461A patent/MY157827A/en unknown
- 2004-06-25 RU RU2005138915/04A patent/RU2374246C2/ru not_active IP Right Cessation
- 2004-06-25 BR BRPI0411916-9A patent/BRPI0411916A/pt not_active IP Right Cessation
- 2004-06-25 AU AU2004253929A patent/AU2004253929A1/en not_active Abandoned
- 2004-06-25 AR ARP040102248A patent/AR044923A1/es unknown
- 2004-06-25 MX MXPA06000144A patent/MXPA06000144A/es unknown
- 2004-06-25 TW TW093118635A patent/TW200514784A/zh unknown
- 2004-06-25 CN CN2004800181459A patent/CN1812789B/zh not_active Expired - Fee Related
- 2004-06-25 WO PCT/US2004/020606 patent/WO2005003064A2/fr not_active Ceased
- 2004-06-25 EP EP04756208A patent/EP1638566A4/fr not_active Withdrawn
- 2004-06-25 KR KR1020057024904A patent/KR20060035637A/ko not_active Ceased
- 2004-06-25 JP JP2006517711A patent/JP2007521280A/ja active Pending
- 2004-06-25 TW TW093118636A patent/TW200511992A/zh unknown
- 2004-06-25 AR ARP040102247A patent/AR044922A1/es unknown
- 2004-06-25 WO PCT/US2004/020607 patent/WO2005003065A2/fr not_active Ceased
- 2004-06-25 CA CA002529322A patent/CA2529322A1/fr not_active Abandoned
- 2004-06-25 NZ NZ544330A patent/NZ544330A/en unknown
-
2005
- 2005-12-07 IL IL172427A patent/IL172427A0/en unknown
-
2006
- 2006-01-26 ZA ZA200600769A patent/ZA200600769B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL172427A0 (en) | 2006-04-10 |
| AR044923A1 (es) | 2005-10-12 |
| WO2005003065A3 (fr) | 2005-03-10 |
| CA2529322A1 (fr) | 2005-01-13 |
| RU2005138915A (ru) | 2006-06-27 |
| TW200511992A (en) | 2005-04-01 |
| AU2004253929A1 (en) | 2005-01-13 |
| WO2005003064A2 (fr) | 2005-01-13 |
| NZ544330A (en) | 2009-06-26 |
| MXPA06000144A (es) | 2006-04-07 |
| KR20060035637A (ko) | 2006-04-26 |
| JP2007521280A (ja) | 2007-08-02 |
| EP1638566A2 (fr) | 2006-03-29 |
| AR044922A1 (es) | 2005-10-12 |
| WO2005003065A2 (fr) | 2005-01-13 |
| EP1638566A4 (fr) | 2009-03-25 |
| CN1812789A (zh) | 2006-08-02 |
| CN1812789B (zh) | 2010-07-14 |
| WO2005003064A3 (fr) | 2005-03-31 |
| RU2374246C2 (ru) | 2009-11-27 |
| MY157827A (en) | 2016-07-29 |
| BRPI0411916A (pt) | 2006-08-15 |
| ZA200600769B (en) | 2007-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY157827A (en) | Sulfonamide substituted imidazoquinolines | |
| MXPA04005362A (es) | Imidazoquinolinas sustituidas con tioeter. | |
| DK1198233T3 (da) | Sulfonamid- og sulfamidsubstituerede imidazoquinoliner | |
| EE200100670A (et) | Amiidasendatud imidasokinoliinid | |
| WO2002046192A3 (fr) | Imidazoquinolines a substitution thioether | |
| MXPA04005331A (es) | Imidazopiridinas sustituidas por sulfonamido. | |
| PL352257A1 (en) | Imidazoquinolines substituted by urea | |
| WO2002046194A3 (fr) | Imidazopyridines substituees | |
| WO2004028539A3 (fr) | Dimeres 1h-imidazo |